Trial intelligence / Profile preview

HEAD head-to-head trial of levetiracetam versus sulthiame in children with benign epilepsy with centro-temporal spikes

2005-004468-22Phase 3Terminated

Sponsor
Dr. von Haunersches Kinderspital
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of levetiracetam and sultiame in Benign Rolandic Epilepsy (BECTS) (2 arms), sponsored by Dr. von Haunersches Kinderspital. Started Aug 2006; status: terminated.

02

Drugs

levetiracetamsultiame
03

Conditions

Benign Rolandic Epilepsy (BECTS)

Beyond the preview

Go deeper on 2005-004468-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004468-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call